Older IBD patients have more biologics side effects and discontinuations

Older patients starting on anti-TNF agents for their IBD need tighter monitoring for adverse events that contribute to treatment failure, research suggests. According to a Dutch study of almost 900 patients, patients commencing anti-TNFs from 60 years of age were more likely to stop treatment due to adverse events than younger patients either <40 years ...

Already a member?

Login to keep reading.

© 2021 the limbic